PMV Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2013-01-01
- Employees
- 63
- Market Cap
- $81.4M
- Website
- http://www.pmvpharma.com
- Introduction
PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in March 2013 and is headquartered in Princeton, NJ.
PMV Pharmaceuticals, Inc. SEC 10-Q Report
PMV Pharmaceuticals' Q3 2024 Form 10-Q reports $21.9M in operating expenses, $19.2M net loss, and $0.37 net loss per share. The company is advancing PC14586 through clinical trials, received FDA Fast Track Designation, and restructured with a 30% workforce reduction. PMV expects to fund operations through 2026 with $197.9M in cash and equivalents.
© Copyright 2024. All Rights Reserved by MedPath